Search Results - "tyrosine kinase"

Extending the duration of response in chronic myelogenous leukemia: targeted therapy with sequential tyrosine kinase inhibitors by Michael G. Martin, John F. DiPersio, Geoffrey L. Uy

Connect to this object online.

FMS-Related Tyrosine Kinase 3 Ligand Promotes Radioresistance in Esophageal Squamous Cell Carcinoma by Zuoquan Zhu, Jiahang Song, Junjie Gu, Bing Xu, Xinchen Sun, Shu Zhang, Shu Zhang

Connect to this object online.

Iterative Upgrading of Small Molecular Tyrosine Kinase Inhibitors for EGFR Mutation in NSCLC: Necessity and Perspective by Jing Zhu, Qian Yang, Weiguo Xu

Connect to this object online.

Multikinase Abl/DDR/Src Inhibition Produces Optimal Effects for Tyrosine Kinase Inhibition in Neurodegeneration by Alan J. Fowler, Michaeline Hebron, Alexander A. Missner, Ruchong Wang, Xiaokong Gao, Bahjat T. Kurd-Misto, Xiaoguang Liu, Charbel E.-H. Moussa

Connect to this object online.

Tyrosine kinase inhibitors: new molecules in non-small cell lung cancer (EGFR AND ALK) by Fernando Franco, Miriam Mendez, Lourdes Gutierrez, Mariano Provencio

Connect to this object online.

Biological evaluation of combinations of tyrosine kinase inhibitors with Inecalcitol as novel treatments for human chronic myeloid leukemia by Luma Al-Ali, Raad J. Al-Ani, Maysaa M. Saleh, Alaa M. Hammad, Duaa A. Abuarqoub, Bashaer Abu-Irmaileh, Abdallah Y. Naser, Manal M. Najdawi, Manal M. Abbas, Jamal Alyoussef Alkrad

Connect to this object online.

Team Management of Skin Rash Associated with Use of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors by Katsuhiro Masago, Fumiko Imamichi, Yoshio Masuda, Noriko Ariga, Kiyomi Fujitomi, Yoko Fukumine, Kana Hatakenaka, Shiro Fujita, Nobuyuki Katakami

Connect to this object online.

Serum Calcium And Phosphateleveelsin Patients With Chronic Myeloid Leukemia Taking Different Dose of Tyrosine Kinase Inhibitors by Bassam Francis Matti, Shahla'a Fadhil Sabir, Maysaa Ali Abdul Khaleq, Marwah Hasan Al kaabi

Connect to this object online.

Safety and Efficacy of Tyrosine Kinase Inhibitors in Immune Thrombocytopenic Purpura: A Systematic Review of Clinical Trials by Muhammad Ashar Ali, Muhammad Yasir Anwar, Wajeeha Aiman, Gurneel Dhanesar, Zainab Omar, Mohammad Hamza, Maha Zafar, Harish Kumar Rengarajan, Michael Maroules

Connect to this object online.

Arterial Hypertension and Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis by Olga Mulas, Giovanni Caocci, Brunella Mola, Giorgio La Nasa

Connect to this object online.

Aldo-keto reductase inhibitors increase the anticancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia by Megumi Kikuya, Kenta Furuichi, Takuya Hirao, Satoshi Endo, Naoki Toyooka, Kousei Ito, Shigeki Aoki

Connect to this object online.

Different roles for non-receptor tyrosine kinases in arachidonate release induced by zymosan and <it>Staphylococcus aureus </it>in macrophages by Sundler Roger, Olsson Sandra

Connect to this object online.

Bruton's Tyrosine Kinase Inhibitor Zanubrutinib Effectively Modulates Cancer Resistance by Inhibiting Anthracycline Metabolism and Efflux by Lucie Čermáková, Jakub Hofman, Lenka Laštovičková, Lucie Havlíčková, Ivona Špringrová, Eva Novotná, Vladimír Wsól

Connect to this object online.

Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer by Zhe Zhang, Sen Yang, Qiming Wang

Connect to this object online.

Addition of bevacizumab to EGFR tyrosine kinase inhibitors in advanced NSCLC: an updated systematic review and meta-analysis by Haosheng Zheng, Xianyu Qin, Yuzhen Zheng, Xingping Yang, Jian Tan, Weijie Cai, Shiyun He, Hongying Liao

Connect to this object online.

Relevance of Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in Routine Clinical Practice: A Pilot Study by Vanesa Escudero-Ortiz, Vanessa Domínguez-Leñero, Ana Catalán-Latorre, Joseba Rebollo-Liceaga, Manuel Sureda

Connect to this object online.

Jak2 Tyrosine Kinase: A Potential Therapeutic Target for AT1 Receptor Mediated Cardiovascular Disease by Peter P. Sayeski, Annet Kirabo

Connect to this object online.

Gain-of-Function Variant in Spleen Tyrosine Kinase Regulates Macrophage Migration and Functions to Promote Intestinal Inflammation by Yang Y, Wang L, Zeng Z, He C, Wang Y, Huang Y

Connect to this object online.

Primary Resistance to EGFR Tyrosine Kinase Inhibitors (TKIs): Contexts and Comparisons in EGFR-Mutated Lung Cancer by Keigo Kobayashi

Connect to this object online.

Brusatol Derivative-34 Attenuates Allergic Airway Inflammation Via Inhibition of the Spleen Tyrosine Kinase Pathway by Yasi Ding, Weibin Tang, Fei Pei, Lixia Fu, Pei Ma, Jinye Bai, Mingbao Lin, Yunbao Liu, Qi Hou

Connect to this object online.